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How reversible are the effects of silver
nanoparticles on macrophages? A proteomic-
instructed view†
Bastien Dalzon,‡a Anaelle Torres,‡a Hélène Diemer,b Stéphane Ravanel,c
Véronique Collin-Faure,a Karin Pernet-Gallay,d Pierre-Henri Jouneau,e
Jacques Bourguignon, c Sarah Cianférani,b Marie Carrière, f
Catherine Aude-Garcia§a and Thierry Rabilloud *a
Silver nanoparticles are known to strongly affect biological systems, and numerous toxicological studies
have investigated their effects. Most of these studies examine the effects immediately following acute ex-
posure. In this work, we have conducted further investigation by studying not only the acute, post-
exposure response, but also the cellular response after a 72 hour-recovery-phase post exposure. As a bio-
logical model we have used macrophages, which are very important cells with respect to their role in the
immune response to particulate materials. To investigate the response of macrophages to nanoparticles
and their recovery post exposure, we have used a combination of proteomics and targeted experiments.
These experiments provided evidence that the cellular reaction to nanoparticles, including the reaction
during the recovery phase, is a very active process involving massive energy consumption. Pathways such
as the oxidative stress response, central and lipid metabolism, protein production and quality control are
strongly modulated during the cellular response to nanoparticles, and restoration of basic cellular homeo-
stasis occurs during the recovery period. However, some specialized macrophage functions, such as
lipopolysaccharide-induced cytokine and nitric oxide production, did not return to their basal levels even
72 hours post exposure, showing that some effects of silver nanoparticles persist even after exposure has
ceased.
1. Introduction
Silver nanoparticles (AgNPs) are used as a biocide in a variety
of consumer and medical products, because of the toxic ef-
fects that they have on microorganisms. However, as an
unwanted side effect, AgNPs also show toxicity to mamma-
lian cells. Thus, numerous toxicological studies have been
conducted both in vitro in bacterial and eukaryotic model cell
systems and in vivo in animal models, including at the micro-
biome level.1–3 Although some studies, especially those using
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Environmental significance
Silver nanoparticles are known to have profound effects on living cells. Because of their widespread use, contamination is almost unavoidable. In this
context, it is important not only to assess the immediate effects of silver nanoparticles on cells, but also how they recover after exposure. Using
macrophages as the target cell type and a combination of proteomic and targeted experiments, we show here that the recovery phase is not just a “return to
normal” condition. For example, some of the specialized macrophage functions are still not restored after this time, showing that subtle but sustained
effects can occur after a single exposure. Although cell survival is not affected, such effects may impact the health status of living beings.
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animal models, have examined the effects of NPs after re-
peated, low-dose exposures,4–8 most of the cellular, toxicolog-
ical studies have been conducted in an acute exposure mode,
meaning that high doses have been used and exposure times
have been short, spanning less than or equal to 24 hours. In
these types of studies, toxicological endpoints are investi-
gated at the end of the exposure period.9–16 In terms of expo-
sure, the acute schemes relate most closely to accidental,
acute exposures, while chronic schemes correspond highly to
occupational exposures. It is of interest to study how biologi-
cal systems recover after a single, high, non-lethal exposure.
This is not a trivial question, as some mineral toxicants such
as beryllium or crystalline silica show very prolonged effects,
even after the exposure has ceased.17,18 This poor recovery
has also been observed for silver nanomaterials such as silver
nanowires19 and silver nanoparticles.20
Many toxicological studies have reported pro-
inflammatory responses5,11,12,21 and/or immunological ef-
fects15,22 pointing to macrophages as a cell type of major
interest in toxicological studies of AgNPs. This is in accor-
dance with the important scavenging function of macro-
phages in many different tissues.
This work investigates the recovery of macrophages af-
ter a unique, acute, but subtoxic dose of AgNPs. Targeted
experiments carried out primarily on macrophages showed
that several functional effects (e.g. LPS-induced cytokine
and NO production, mitochondrial transmembrane poten-
tial and phagocytosis) were altered immediately after expo-
sure to AgNPs. However, these functions tended to return
to normal after a 72 h recovery period.23 We therefore de-
cided to get a broader view of cellular recovery using a
proteomic approach.
Proteomic approaches have been used to study cellular
responses to AgNPs in several models such as intestinal
cells9,24,25 or liver cells.10 This allowed several important
pathways modulated in response to acute exposures to
AgNPs to be highlighted. These included mitochondrial
proteins, pointing at potential mitochondrial dysfunc-
tion,9,10,24 and proteins involved in intermediate metabo-
lism9,10,24 or in inflammatory responses.10 The latter find-
ings reinforced the interest in studying macrophages,
which are major players in inflammation. We therefore
decided to use proteomics to study the cellular responses
using a macrophage J774 cell line, directly after acute ex-
posure and after a recovery period had lapsed. This model
cell line was selected because, unlike human monocyte
cell lines,26,27 mouse macrophage cell lines such as
RAW264.7 and J774 do not need to be chemically differen-
tiated into macrophages, a process that deeply alters cell
physiology and causes some cell death. Furthermore, as
opposed to primary macrophages derived from human
blood, these mouse cell lines do not show extensive vari-
ability from one experiment to another. This explains why
these cell lines are extensively used as models for testing
of a wide variety of nanomaterials,28–31 including large
scale projects.32–34
2. Experimental
Most experiments have been performed essentially as de-
scribed in previous publications.35–37 Details are given here
for the sake of the consistency of the paper. All biological ex-
periments were carried out at least on three independent bio-
logical replicates.
2.1 Nanoparticles
PVP-coated silver nanoparticles were purchased from Sigma,
directly as a concentrated suspension (catalog number
#758329). Their characteristics have been published previ-
ously.23,38 These experiments confirmed the manufacturer's
data and showed that the nanoparticles are spherical, with a
diameter in the 50–110 nm range, and did not aggregate
upon dilution in water or culture medium.
2.2 Cell culture
The mouse macrophage cell line J774 was obtained from the
European Cell Culture Collection (Salisbury, UK). The cells
were cultured in DMEM + 10% fetal bovine serum (FBS). For
routine culture, cells were seeded in non-adherent flasks (e.g.
suspension culture flasks from Greiner) at 200 000 cells per
ml and harvested 48 hours later, at 1 000 000 cells per ml.
Cell viability was measured by a dye exclusion assay, either
with eosin (1 mg ml−1)39 under a microscope or with
propidium iodide (1 μg ml−1)40 in a flow cytometry mode.
For determination of the useful dose, cells were seeded at
500 000 cells per ml. They were treated with nanoparticles on
the following day and harvested after a further 24 hours in
culture.
For treatment with nanoparticles, cells were seeded in
classical cell culture flasks and left for 24 hours at 37 °C for
cell adhesion and confluence. For the recovery condition,
cells were treated with nanoparticles on the following day. Af-
ter 24 hours of exposure, the cell culture medium was re-
moved and replaced by fresh medium. For consistency rea-
sons, this operation was also carried out on cells used for
control and for acute exposure. Another medium culture
change was carried out 36 hours after the initial medium
change, i.e. mid-term of the 72 hour recovery period. Finally,
acute exposure was carried out for the final 24 hours and the
cells were used immediately afterwards.
2.3 Phagocytosis and particle internalization assay
The phagocytic activity was measured using fluorescent latex
beads (1 μm diameter, green labelled, catalog number L4655
from Sigma). The beads were pre-incubated at a final concen-
tration of 55 μg mL−1 for 30 minutes at 37 °C in PBS/FBS (v/
v). Then, they were incubated with cells (5 μg mL−1) for 2 h
30 at 37 °C. Cells were harvested and washed with PBS. Cells
were resuspended by vortexing with addition of 3/4 water vol-
ume and then 1/4 NaCl (35 mg mL−1) volume was added un-
der vortexing in order to clean the cell surface of adsorbed
particles. Cells were harvested in PBS with propidium iodide
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(1 μg mL−1). Viability and phagocytic activity were measured
simultaneously by flow cytometry on a FacsCalibur instru-
ment (Beckton Dickinson). The dead cells (propidium posi-
tive) were excluded from the analysis.
2.4 Mitochondrial transmembrane potential measurement
The mitochondrial transmembrane potential was assessed by
rhodamine 123 uptake. Cells were incubated with rhodamine
123 (80 nM) for 30 minutes at 37 °C, 5% CO2 then rinsed
twice in cold glucose (1 mg mL−1)–PBS (PBSG) and harvested
in cold PBSG supplemented with propidium iodide (1 μg
mL−1). The mitochondrial potential of the cells was analysed
by flow cytometry on a FacsCalibur instrument (Beckton
Dickinson). The dead cells (propidium positive) were ex-
cluded from the analysis. The low rhodamine concentration
was used to avoid intramitochondrial fluorescence quenching
that would result in a poor estimation of the mitochondrial
potential.41
2.5 Enzyme assays
The enzymes were assayed according to published procedures
(see below).
The cell extracts for enzyme assays were prepared by lysing
the cells for 20 minutes at 0 °C in Hepes (20 mM, pH 7.5),
MgCl2 (2 mM), KCl (50 mM), EGTA (1 mM), and tetra-
decyldimethylammonio propane sulfonate (SB 3-14) (0.15%
(w/v)), followed by centrifugation at 15 000g for 15 minutes to
clear the extract. The protein concentration was determined
by a dye-binding assay.42 The dehydrogenase or
dehydrogenase-coupled activities were assayed at 500 nm
using the phenazine methosulfate/iodonitrotetrazolium
coupled assay.43 The enzyme assay buffer contained 25 mM
Hepes, NaOH (pH 7.5), 5 mM magnesium acetate, 100 mM
potassium nitrate and 1% Triton X-100. It also contained 30
μM phenazine methosulfate, 200 μM iodonitrotetrazolium
chloride, 250 μM of the adequate cofactor (NAD or NADP)
and 1–5 mM of the organic substrate, which was used to start
the reaction. For phosphate-dependent enzymes such as glyc-
eraldehyde dehydrogenase (GAPDH) and purine phosphory-
lase (PNPH), 50 mM potassium phosphate (pH 7.5) was
added to the enzyme assay buffer. Triose phosphate isomer-
ase was assayed with dihydroxyacetone phosphate and a glyc-
eraldehyde dehydrogenase-coupled assay.44 Purine phosphor-
ylase (PNPH) was assayed by a xanthine oxidase-coupled
assay.45 Hexokinase was assayed by a glucose phosphate de-
hydrogenase (G6PDH)-coupled assay.46 Biliverdine reductase
was assayed at 450 nm as described.47 Pyridoxal kinase was
assayed directly at 388 nm.48 Enolase was assayed at 340 nm
by a pyruvate kinase–lactate dehydrogenase-coupled assay.49
2.6 NADP/NADPH and glucose assays
The glucose concentration in conditioned media was deter-
mined by a hexokinase–G6PDH assay.50 Briefly, culture media
collected at the end of the exposure period were centrifuged
for 15 min at 15 000g to pelletize the particulate material.
The supernatant was collected, and diluted 100-fold in the
dehydrogenase assay buffer described above, containing also
1 mM EGTA, 30 μM phenazine methosulfate, 200 μM iodo-
nitrotetrazolium chloride, 10 IU ml−1 G6PDH and 7.5 IU ml−1
hexokinase. The reaction was started by the addition of ATP
(1 mM final concentration) and the increase in absorbance at
500 nm read for 1 minute. The linear part of the absorbance
curve was used to determine the reaction speed, which was
proportional to the glucose concentration. Fresh culture me-
dia supplemented with 10% fetal calf serum, i.e. high glucose
DMEM (4.5 g L−1 glucose), RPMI1640 (2 g L−1 glucose) and
199 medium (1 g L−1 glucose) were used as standards.
The NADP–NADPH concentration was determined using
an adapted alkaline extraction buffer.51 Briefly, at the end of
the exposure period, cells were collected by scraping, rinsed
twice in PBS and pelleted. The packed cell pellet (PCP) vol-
ume was estimated, and the cells were lysed in 10 PCP vol-
umes of 10 mM CAPS, 1 mM EGTA and 2 mM MgCl2 for 10
minutes on ice with occasional vortexing. The suspension
was centrifuged (10 000g, 5 minutes, 4 °C), the viscous cell
pellet discarded and the supernatant collected and split into
two aliquots. The first aliquot was neutralized on ice by
adding 0.1 volume of 1 M tricine. This aliquot contained
both the oxidized and reduced forms of the pyridine nucleo-
tides, and was also used to determine the protein concentra-
tion by a dye-binding assay.42
The other aliquot was heated at 60 °C for 30 minutes in a
thermostated water bath to destroy the oxidized forms of the
pyridine nucleotides.51 It was then cooled on ice, neutralized
by adding 0.1 volume of 1 M tricine, and centrifuged for 10
minutes at 10 000g at 4 °C to eliminate any particulate
material.
The NADP–NADPH concentration was then determined by
using an enzyme cycling assay and standard NADP
solutions.52
2.7 NO production and cytokine production
The cells were grown to confluence in a 6-well plate and pre-
treated with nanoparticles as described above. For the final
18 hours of culture, half of the wells were treated with 100 ng
ml−1 LPS (from salmonella, purchased from Sigma), and argi-
nine monohydrochloride was added to all the wells (5 mM fi-
nal concentration) to give a high concentration of the sub-
strate for nitric oxide synthase. After 18 hours of incubation,
the cell culture medium was recovered and centrifuged at
10 000g for 10 minutes to remove cells and debris, and the ni-
trite concentration in the supernatants was read at 540 nm
after addition of an equal volume of Griess reagent and incu-
bation at room temperature for 30 minutes.
For cytokine production, a commercial kit (BD Cytometric Bead
Array, catalog number 552364 from BD Biosciences) was used.
2.8 F-actin staining
The experiments were performed essentially as previously de-
scribed.53 The cells were recovered at the mid-term medium
Environmental Science: Nano Paper
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change (see above) and cultured on coverslips placed in
6-well plates. For the acute exposure condition, the cells were
exposed to silver nanoparticles for 24 h at 37 °C. At the end
of the exposure time, the cells were washed twice for 5 min
at 4 °C in PBS and fixed in 4% paraformaldehyde for 30 min
at room temperature. After two washes (5 min/4 °C in PBS),
they were permeabilized in 0.1% Triton X100 for 5 min at
room temperature. After two more washes in PBS, 500 nM
Phalloidin-Atto 550 (Sigma) was added to the cells and left
for 20 min at room temperature in the dark. Coverslip-
attached cells were washed, placed on microscope slides
(Thermo Scientific) using a Vectashield mounting medium
containing DAPI (Eurobio) and imaged using a Zeiss LSM
800 confocal microscope. The images were processed using
ImageJ software.
2.9 Silver assay by ICP-MS
For measuring the Ag-NP uptake and release in cells, 2 mL
cell cultures in 6-well plates were used, with the exposure
scheme described above in section 2.2. At the end of the ex-
posure period, the culture medium was removed and saved
and the cell layer was gently rinsed twice with culture me-
dium without serum.
The cells were then lysed by scraping in 2 ml of lysis buffer
(50 mM Hepes (pH 7.5), 4 mM magnesium acetate, 200 mM
sorbitol, and 0.1% (w/v) tetradecyldimethylammonio propane
sulfonate (SB 3-14)). The lysate was pipetted into a microtube
and incubated for 20 minutes on ice to complete cell lysis. For
determination of soluble silver, aliquots of the culture media
and of the cell lysates were centrifuged for 45 minutes at
16 000g, and the upper half of the supernatant was collected.
The samples were mineralized by the addition of one vol-
ume of suprapure 65% HNO3 and incubation on a rotating
wheel at room temperature for 18 h.
Mineralized samples were diluted in 0.5% (v/v) HNO3 and
analysed using an iCAP RQ quadrupole mass instrument
(Thermo Fisher Scientific GmbH, Germany) equipped with
an ASX-560 auto-sampler (Teledyne CETAC Technologies,
Omaha, USA). The instrument was used with a MicroMist
U-Series glass concentric nebulizer, a quartz spray chamber
cooled at 3 °C, a Qnova quartz torch, a nickel sample cone,
and a nickel skimmer cone equipped with a high-sensitivity
insert. 24Mg, 25Mg, 107Ag and 109Ag concentrations were deter-
mined using standard curves and corrected using an internal
standard solution of 103Rh added online. Data integration
was done using the Qtegra software (version 2.8.2944.115).
The results were normalized using the Mg concentration (4
mM in the cellular extracts and 0.82 mM in culture medium).
To take into account the cellular concentration effects, the
protein concentration of the extracts was determined by a
dye-binding assay.42
2.10 Proteomics
The 2D gel-based proteomic experiments were essentially car-
ried out as previously described,35 at least on independent
biological triplicates. However, detailed materials and
methods are provided for the sake of paper consistency.
2.10.1 Sample preparation. The cells were collected by
scraping and then washed three times in PBS. The cells were
then washed once in TSE buffer (10 mM Tris-HCl (pH 7.5),
0.25 M sucrose, and 1 mM EDTA), and the volume of the cell
pellet was estimated. The pellet was resuspended in its own
volume of TSE buffer. Then 4 volumes (respective to the cell
suspension just prepared) of concentrated lysis buffer (8.75
M urea, 2.5 M thiourea, 5% w/v CHAPS, 6.25 mM TCEP-HCl,
20 mM spermine base, and 20 mM spermine tetra-
hydrochloride) were added and the solution was left to ex-
tract at room temperature for 1 hour. The nucleic acids were
then pelleted by centrifugation (270 000g at room tempera-
ture for 1 h), and the protein concentration in the superna-
tant was determined by a dye-binding assay.42 Carrier
ampholytes (Pharmalytes, pH 3–10) were added to a final
concentration of 0.4% (w/v), and the samples were kept fro-
zen at −20 °C until use.
2.10.2 Isoelectric focusing. Home-made 160 mm long 4–
8 linear pH gradient gels54 were cast according to published
procedures.55 Four mm-wide strips were cut and rehydrated
overnight with the sample, diluted to a final volume of 0.6
ml of the rehydration solution (7 M urea, 2 M thiourea, 4%
CHAPS, 0.4% carrier ampholytes (Pharmalytes 3–10) and 100
mM dithiodiethanol).56
The strips were then placed in a Multiphor plate (GE
Healthcare), and IEF was carried out with the following elec-
trical parameters: 100 V for 1 hour, then 300 V for 3 hours,
then 1000 V for 1 hour, then 3400 V up to 60–70 kVh. After
IEF, the gels were equilibrated for 20 minutes in 125 mM
Tris, 100 mM HCl, 2.5% SDS, 30% glycerol and 6 M urea.57
They were then transferred on top of the SDS gels and sealed
in place with 1% agarose dissolved in 125 mM Tris, 100 mM
HCl, 0.4% SDS and 0.005% (w/v) bromophenol blue.
2.10.3 SDS electrophoresis and protein detection. Ten per-
cent gels (160 × 200 × 1.5 mm) were used for protein separa-
tion. The Tris taurine buffer system58 was used and operated
at an ionic strength of 0.1 and a pH of 7.9. The final gel com-
position is thus 180 mM Tris, 100 mM HCl, 10% (w/v) acryl-
amide, and 0.27% bisacrylamide. The upper electrode buffer
is 50 mM Tris, 200 mM taurine, and 0.1% SDS. The lower
electrode buffer is 50 mM Tris, 200 mM glycine, and 0.1%
SDS. The gels were run at 25 V for 1 hour, then 12.5 W was
applied per gel until the dye front reached the bottom of the
gel. Detection was carried out by tetrathionate silver
staining59 .
2.10.4 Image analysis and global analysis of the spot abun-
dance data. The gels were scanned after silver staining on a
flatbed scanner (Epson perfection V750), using 16 bit gray-
scale image acquisition. The gel images were then analyzed
using the Delta 2D software (v 3.6). The spots that were never
expressed above 100 ppm of the total spots were first filtered
out. Then, significantly-varying spots were selected on the ba-
sis of their Student's T-test p-value between the treated and
the control groups. Spots showing a p-value lower than 0.05
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were selected. This strategy is used to avoid the use of arbi-
trary thresholds, which can result in discarding statistically-
valid relevant changes and including non-valid changes.60
The false positive concern was taken into account using sev-
eral approaches such as the Benjamini Hochberg approach,61
the sequential goodness of fit approach62 and the sequential
Fisher test approach.63 Furthermore, we checked that all the
spots that we found through the T-test also had a p < 0.05 in
a non-parametric Mann–Whitney U-test.
For the global analysis of the spot abundance data, we
used directly the spot abundance data as provided by the gel
analysis software. The software directly normalizes each spot
abundance by the sum of all spot abundances detected on
the gel. These relative abundance data were used directly for
global analysis using the PAST software suite64 without any
transformation. No limitation in the number of principal
components was implemented in the principal component
analysis.
2.10.5 Mass spectrometry. The spots selected for identifi-
cation were excised from silver-stained gels and destained
with ferricyanide/thiosulfate on the same day as silver
staining in order to improve the efficiency of the identifica-
tion process.65,66 In-gel digestion was performed with an au-
tomated protein digestion system, MassPrep Station (Waters,
Milford, USA). The gel plugs were washed twice with 50 μL of
25 mM ammonium hydrogen carbonate (NH4HCO3) and 50
μL of acetonitrile. The cysteine residues were reduced by 50
μL of 10 mM dithiothreitol at 57 °C and alkylated by 50 μL of
55 mM iodoacetamide. After dehydration with acetonitrile,
the proteins were cleaved in the gel with 10 μL of 12.5 ng
μL−1 modified porcine trypsin (Promega, Madison, WI, USA)
in 25 mM NH4HCO3. The digestion was performed overnight
at room temperature. The generated peptides were extracted
with 30 μL of 60% acetonitrile in 0.1% formic acid. Acetoni-
trile was evaporated under vacuum before nanoLC-MS/MS
analysis.
NanoLC-MS/MS analysis was performed using a nano-
ACQUITY Ultra-Performance-LC (Waters Corporation, Mil-
ford, USA) coupled to a Synapt™ High Definition Mass
Spectrometer™ (Waters Corporation, Milford, USA), or to a
TripleTOF 5600 (Sciex, Ontario, Canada).
The nanoLC system was composed of an ACQUITY
UPLC® CSH130 C18 column (250 mm × 75 μm with a 1.7
μm particle size, Waters Corporation, Milford, USA) and a
symmetry C18 precolumn (20 mm × 180 μm with a 5 μm
particle size, Waters Corporation, Milford, USA). The sol-
vent system consisted of 0.1% formic acid in water (solvent
A) and 0.1% formic acid in acetonitrile (solvent B). 4 μL of
the sample were loaded into the enrichment column over 3
min at 5 μL min−1 with 99% of solvent A and 1% of sol-
vent B. Elution of the peptides was performed at a flow
rate of 300 nL min−1 with a 8–35% linear gradient of sol-
vent B in 9 minutes.
The Synapt™ High Definition Mass Spectrometer™ (Wa-
ters Corporation, Milford, USA) was equipped with a Z-spray
ion source and a lock mass system. The system was fully con-
trolled by MassLynx 4.1 SCN639 (Waters Corporation, Mil-
ford, USA). The capillary voltage was set at 2.8 kV and the
cone voltage at 35 V. Mass calibration of the TOF was
achieved using fragment ions from Glu-fibrino-peptide B in
the [50;2000] m/z range. Online correction of this calibration
was performed with Glu-fibrino-peptide B as the lock-mass.
The ion (M + 2H)2+ at m/z 785.8426 was used to calibrate MS
data and the fragment ion (M + H)+ at m/z 684.3469 was used
to calibrate MS/MS data during the analysis.
For tandem MS experiments, the system was operated
with automatic switching between the MS (0.5 s per scan in
the m/z range [150;1700]) and MS/MS mode (0.5 s per scan in
the m/z range [50;2000]). The two most abundant peptides
(intensity threshold 20 counts per s), preferably doubly and
triply charged ions, were selected in each MS spectrum for
further isolation and CID fragmentation using a collision en-
ergy profile. Fragmentation was performed using argon as
the collision gas.
Mass data collected during analysis were processed and
converted into .pkl files using ProteinLynx Global Server 2.3
(Waters Corporation, Milford, USA). Normal background sub-
traction was used for both MS and MS/MS with a 5% thresh-
old and polynomial correction of order 5. Smoothing was
performed on MS/MS spectra (Savitzky–Golay, 2 iterations,
window of 3 channels). Deisotoping was applied for MS (me-
dium deisotoping) and for MS/MS (fast deisotoping).
The TripleTOF 5600 (Sciex, Ontario, Canada) was oper-
ated in positive mode, with the following settings: ion spray
voltage floating (ISVF) 2300 V, curtain gas (CUR) 10, inter-
face heater temperature (IHT) 150, ion source gas 1 (GS1)
2, declustering potential (DP) 80 V. The information-
dependent acquisition (IDA) mode was used with Top 10
MS/MS scans. The MS scan had an accumulation time of
250 ms in the m/z [400;1250] range and the MS/MS scans
100 ms in the m/z [150;1800] range in high sensitivity
mode. Switching criteria were set to ions with a charge
state of 2–4 and an abundance threshold of more than 500
counts; the exclusion time was set at 4 s. The IDA rolling
collision energy script was used for automatically adapting
the CE. Mass calibration of the analyser was achieved using
peptides from digested BSA. The complete system was fully
controlled by AnalystTF 1.7 (Sciex). Raw data collected were
processed and converted with MSDataConverter in the .mgf
peak list format.
For protein identification, the MS/MS data were inter-
preted using a local Mascot server with the MASCOT 2.4.1
algorithm (Matrix Science, London, UK) against
UniProtKB/SwissProt (version 2016_01, 550 299 sequences).
The research was carried out in all species. Spectra were
searched with a mass tolerance of 15 ppm for MS and
0.05 Da for MS/MS data, allowing a maximum of one
trypsin missed cleavage. Carbamidomethylation of cysteine
residues and oxidation of methionine residues were speci-
fied as variable modifications. Protein identifications were
validated with at least two peptides with a Mascot ion
score above 30.
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2.11 Electron microscopy
J774 macrophage cells were grown on coverslips and treated
with AgNPs as described above. Cells were allowed to recover
for 72 hours before being fixed with 2.5% glutaraldehyde in
0.1 M cacodylate buffer (pH 7.4) for 2 hours at room tempera-
ture. Cells were then washed with buffer, post fixed with 1%
osmium tetroxide in the same buffer for 1 hour at 4°, and
washed with water. Cells were then dehydrated through a se-
ries of graded alcohol (30–60–90–100–100–100%) and infil-
trated with a mix of 1/1 epon/alcohol (100%) for 1 hour be-
fore several baths of fresh epon (Fluka) for 3 hours. Finally, a
capsule full of epon was placed on the surface of the cells
and the resin was allowed to polymerise for 72 h at 60 °C.
The polymerised bloc was then detached from the coverslip
with HF (48%) over 1 hour. Ultrathin sections of the cell
monolayer were cut with an ultramicrotome (Leica). For
transmission electron microscopy (TEM) observation, the sec-
tions were post-stained with 5% uranyl acetate and 0.4% lead
citrate and observed with a transmission electron microscope
at 80 kV (JEOL 1200EX). Images were acquired with a digital
camera at magnification ranging from 15k to 50k (Veleta,
Olympus). For scanning transmission electron microscopy
observation (STEM) and energy dispersive spectroscopic anal-
ysis (EDS), the sections were not post-stained. They were
coated with a thin layer of carbon and observed and analyzed
with an OSIRIS microscope (TECNAI) operating at 200 kV.
3. Results
3.1 Silver accumulation upon treatment with silver
nanoparticles and after recovery
First, the effect of silver nanoparticles and soluble silver on cell
viability was assayed, and the results are shown in Fig. 1. For all
the subsequent experiments, a dose of 20 μg ml−1 was selected,
corresponding to the lethal dose 20% (LD20). This dose ensures
strong effects on cells while keeping cellular mortality at an ac-
ceptable level for subsequent experiments. We also checked the
presence of nanoparticles in cells by electron microscopy. Con-
trol cells did not show any electron-dense materials
(Fig. 2A and B), while cells exposed to Ag nanoparticles acutely
showed some electron-dense particles located in large mem-
brane compartments called macropinosomes (Fig. 2C and D).
After the recovery period, these electron dense particles were
still observed in the macropinosomes (Fig. 2E and F). Energy
dispersive spectroscopic analysis of these electron-dense fea-
tures confirmed that they contained Ag (Fig. 2G–I).
Silver accumulation in cells was measured by ICP-MS. The
results are summarized in Table 1. They showed a strong ac-
cumulation of silver in cells at the end of the 24 hour expo-
sure followed by a moderate loss of total silver. The cells were
able to cycle once during the 72 h recovery period, as shown
by the increase in the protein amount in the extracts, which
resulted in a further reduction of the cellular silver content.
A moderate but detectable silver excretion was also
evidenced. It should be also noted that the protein concentra-
tion is used in toxicology as an indicator for cell number,67,68
3.2 Global analysis of the proteomic results
From the total protein expression data obtained from the gel
analysis software, a subset of variable proteins (p < 0.25 in ei-
ther the acute vs. control or the recovery vs. control compari-
sons) was extracted. This allowed the noise brought by pro-
teins that do not show a consistent variation in the biological
phenomena under investigation to be decreased. This subset
was then tested using the PAST statistical suite.64 As a first
test, a hierarchical clustering was performed, and the results
are shown in Fig. 3A. Clustering clearly separates the control
group from the two silver-treated ones, but gives no informa-
tion regarding which silver treatment condition is closer to the
control. Principal component analysis gave a more valuable in-
dication, as shown in Fig. 3B. The recovery group appeared to
be in an intermediate position between the control and acute
groups along component one, which carries most of the vari-
ance. This is an expected position in a “return to normal”
model during the recovery phase. However, the recovery group
separated from both the control and the acute groups in com-
ponent 2. This suggested that the three conditions were fairly
different from each other. This was further confirmed by anal-
ysis of similarities (ANOSIM), which gave the following results
for the p-values of the pairwise comparisons:
Fig. 1 Dose response curve to silver nanoparticles and ionic silver.
Cell viability was measured by dye exclusion. The cells were exposed
to silver nanoparticles (panel A) or silver lactate (panel B) for 24 hours
before measurement of cell viability (n = 3).
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p = 0.031 for the acute vs. control comparison
p = 0.032 for the recovery vs. control comparison
p = 0.027 for the acute vs. recovery comparison
These figures suggest that the recovery phase was a very ac-
tive state, which did not represent just an intermediate state
between the control and the acute stage, i.e. immediately af-
ter exposure to silver nanoparticles. To further investigate
this aspect, we extracted the intensity values for the spots
that were significantly altered (p < 0.05) between the control
group and at least one of the silver-treated groups. In order
Fig. 2 Ag distribution in macrophages. Control cells (A and B) or cells exposed to Ag nanoparticles (C–G) were imaged by transmission electron
microscopy (A–F) or scanning transmission electron microscopy (G). Panels A and B: control cells; panels C and D: cells acutely exposed to Ag
nanoparticles; panels E and F: recovering cells. A, C and E: High contrast images; B, D and F: low contrast images highlighting the presence of
electron-dense materials, which are probably Ag nanoparticles or debris of Ag nanoparticles (*). Panel G is a HAADF image of a multilamellar body
containing electron-dense materials. H and I: Chemical element distribution of the area of G delimited by the white square, analyzed by energy
dispersive spectroscopy. Panel H shows the Ag distribution and panel I shows the EDS spectra of area1 (an intracellular region containing some
Ag) and area2 (an intracellular region that does not contain any Ag) of H.
Table 1 Measurements of silver concentrations
Unexposed Exposed to 20 μg ml−1 AgNPs 72 h recovery after exposure to AgNPs
Protein concentration in the cell extract (mg ml−1) 0.352 ± 0.02 0.322 ± 0.02 0.657 ± 0.04
Total silver concentration in the cell extract (μg l−1) 0 9794 ± 1159 8258 ± 1536
Soluble silver concentration in the cell extract (μg l−1) 0 39.86 ± 11.83 47.57 ± 3.11
Soluble silver concentration in culture medium (μg l−1) 457 ± 64a 142 ± 4
Normalized silver content (ng Ag mg−1 protein) 0 30 608 ± 5055 12 530 ± 1984
Soluble silver fraction in cells 0 0.0041 ± 0.0014 0.0059 ± 0.001
Fraction of silver excretedb 0 ND 0.017 ± 0.003
a This value contains both the soluble silver that is actively excreted by cells during the exposure and the soluble silver that arises from
nanoparticle dissolution directly in the culture medium. b Defined as soluble silver in medium/total silver (i.e. silver in medium + silver in cells).
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to cope with the multiple testing issue, we used several ap-
proaches such as the Benjamini Hochberg approach,61 the se-
quential goodness of fit approach62 and the sequential Fisher
test approach.63 All the selected spots showed a very low
q-value for the condition for which they were variable com-
pared to the control (Table S1†).
We then divided this dataset of 239 spots into lists (Table
S2†). The first list, labelled as “returning spots”, contained the
spots for which the amplitude of the change in abundance be-
tween the recovery and control stages is lower than the ampli-
tude of the change in abundance between the acute exposure
and control stages. 135 spots belonged to this list. It was then
divided into subsets. The first subset contained “fast returning
spots”. It was defined as spots for which the quantitative
change in the acute vs. control comparison shows an ampli-
tude at least twice that in the recover vs. control comparison
(i.e. more than 50% convergence). 44 spots belonged to this
subset. The other subset of this list contained the 91 “slow
returning spots”, for which the return-to-normal trend was
lower than 50% in the 72 hour recovery period.
The other list, labelled as “diverging spots”, contained the
104 spots for which the amplitude of the change in abun-
dance between the recovery and control stages is higher than
the amplitude of the change in abundance between the acute
exposure and control stages. This list was also divided into
subsets. The “fast diverging spots” subset was defined as the
spots for which the quantitative change in the recover vs.
control comparison was at least 1.5 higher than the quantita-
tive change in the acute vs. control comparison (i.e. more
than 50% divergence). 53 spots belonged to this subset. The
other subset of this list contained the 51 “slow diverging
spots”, for which the diverging trend was lower than 50% in
the 72 hour recovery period.
3.3 Detailed analysis of the proteomic results
In order to gain more precise insights, we investigated which
proteins were significantly altered (p < 0.05) between the
control group and at least one of the silver-treated groups.
The list of modulated proteins is given in Table 2 and the
corresponding 2D gel images are shown in Fig. 4. As 2D gels
separate protein forms, a variation in a spot does not neces-
sarily mean that the whole amount of the protein is modu-
lated. In fact, a single protein can be represented by various
2D gel spots, which do not necessarily all change upon the
treatment with nanoparticles. To alleviate this problem, we
systematically identified by mass spectrometry not only the
modulated spots, but also the neighboring spots to check for
such isoform issues. The quantitative results have been inte-
grated in Table 2 and the mass spectrometry identification
parameters are detailed in Table S3.† The results for some
classes (apoptosis, cell fate and energy metabolism) are also
shown in gel images in Fig. 4, and the results for the other
classes are shown in Fig. S1–S5.† For global analysis of the
modulated proteins, we used the DAVID annotation tool,69,70
available at https://david.ncifcrf.gov/, and the results are
shown in Tables S4 and S5.† The results showed that some
functional classes such as energy metabolism, cytoskeleton
especially actin cytoskeleton, protein folding and quality con-
trol (especially the ubiquitin/proteasome pathway), nucleo-
tide and nucleic acid metabolism, cell signaling, oxidative
stress response and detoxification proteins are strongly repre-
sented among the modulated proteins. This prompted us to
carry out validation experiments on some of these proteins or
pathways.
3.4 Enzymatic activities
For some of the modulated proteins, we first checked
whether their enzyme activities (Table 3), i.e. the relevant pa-
rameter in terms of cell physiology, followed or not the
trends observed via proteomics. There is no obvious infer-
ence between the two parameters, as the activity may be mod-
ulated by PTM and thus correlate with one or several spots,
or with the sum of the spots representing the same protein.
One good example is represented by malate dehydrogenase,
Fig. 3 Global analysis of proteomic data. Global data analysis was performed on the proteomic data to derive the relationships between the
various samples used. Panel A: Hierarchical clustering. The Euclidean distance similarity index and Ward's algorithm were used for this analysis. C1–
C4: Control (non-exposed) cells. A1–A4: Acutely exposed cells (24 hours). R1–R4: Recovering cells (72 hours post-exposure). Panel B: Principal
component analysis. A representation displaying the first two principal components is shown. The PCA yielded 11 components, of which the first
two, represented in the figure, explained 70% of the total variance (axis 1 – 54%, axis 2 – 16%). Component 3 explained 7.5% of the variance,
component 4 explained 6%, and the remaining components explained less than 4% of the variance each. Samples labelled as in panel A.
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Table 2 Differentially-expressed proteins identified in the proteomic screen
Spot number Protein name Accession number Ratio acute/ctrl T test acute vs. ctrl Ratio recov/ctrl T test recov vs. ctrl
A1 Casp3 P70677 0.59 0.04 1.00 0.99
A2 Efhd2 Q9D8Y 1.24 0.02 1.18 0.23
C1 Actin P60710 1.51 <0.01 1.67 0.01
C2a Actn4/1 P57780 1.45 0.04 1.18 0.16
C2b Actn4/2 P57780 1.43 0.04 1.38 0.01
C2c Actn4/3 P57780 1.25 0.33 1.17 0.03
C2d Actn4/4 P57780 1.44 0.20 1.28 0.05
C2S
P
Actn4 P57780 1.36 0.16 1.23 0.02
C3a Arp2/1 P61161 0.90 0.06 0.76 <0.01
C3b Arp2/2 P61161 1.10 0.41 0.94 0.63
C3c Arp2/3 P61161 1.19 0.04 1.32 <0.01
C3S
P
Arp2 P61161 1.15 0.07 1.14 0.06
C4a Arpc2/1 Q9CVB6 0.57 0.03 0.52 0.02
C4b Arpc2/2 Q9CVB6 0.76 0.04 0.78 0.06
C4c Arpc2/3 Q9CVB6 0.91 0.51 1.12 0.41
C4S
P
Arpc2 Q9CVB6 0.80 0.11 0.90 0.39
C5a Arpc5/1 Q9CPW4 0.59 0.03 0.25 0.01
C5b Arpc5/2 Q9CPW4 1.06 0.51 0.99 0.90
C5S
P
Arpc5 Q9CPW4 0.88 0.30 0.71 0.04
C6a Capg/1 P24452 0.81 0.01 1.00 0.97
C6b Capg/2 P24452 1.16 0.15 1.04 0.58
C6S
P
capg P24452 0.35 0.39 0.35 0.39
C7 Capza2 P47754 1.30 0.01 1.28 0.01
C8a Capzb/1 P47757 1.07 0.37 1.20 0.06
C8b Capzb/2 P47757 0.80 0.02 1.01 0.95
C8S
P
capzb P47757 0.98 0.60 1.13 0.14
C9a Cof/1 P18760 0.67 0.05 0.60 0.03
C9b Cof/2 P18760 1.49 0.01 1.26 0.10
C9c Cof/3 P18760 0.74 <0.01 0.73 <0.01
C9S
P
Cof P18760 0.86 0.02 0.79 <0.01
C10a Dyncli2/1 O88487 1.21 0.49 2.20 <0.01
C10b Dyncli2/2 O88487 1.43 0.26 1.69 0.04
C10S
P
dyncli2 O88487 1.36 0.30 1.84 0.01
C11a Gelsolin/1 P13020 1.16 0.44 0.94 0.71
C11b Gelsolin/2 P13020 1.16 0.36 1.00 0.97
C11c Gelsolin/3 P13020 1.39 0.16 1.27 0.26
C11d Gelsolin/4 P13020 1.57 0.05 1.32 0.13
C11S
P
gelsolin P13020 1.33 0.15 1.15 0.39
C12 Gmfg Q9ERL7 0.54 <0.01 0.66 <0.01
C13 Lasp1 Q61792 0.41 <0.01 0.38 <0.01
C14 Ml12b Q3THE2 0.92 0.51 0.81 0.01
C15a Moesin/1 P26041 0.94 0.75 0.86 0.41
C15b Moesin/2 P26041 0.90 0.53 0.78 0.08
C15c Moesin/3 P26041 1.22 0.17 0.89 0.13
C15d Moesin/4 P26041 1.18 0.07 1.09 0.10
C15e Moesin/5 P26041 1.52 0.03 1.24 0.04
C15S
P
Moesin P26041 1.20 0.08 1.01 0.91
C16 Mtap Q9CQ65 1.04 0.83 1.30 0.02
C17 RhoA Q9QUI0 0.59 <0.01 0.76 0.02
C18a Rhogdi1/1 Q99PT1 0.71 <0.01 0.67 <0.01
C18b Rhogdi1/2 Q99PT1 1.16 0.13 1.11 0.08
C18S
P
RhoGdi1 Q99PT1 0.99 0.85 0.95 0.28
C19a Rhogdi2/1 Q61599 0.64 <0.01 0.54 <0.01
C19b Rhogdi2/2 Q61599 1.00 0.99 0.95 0.17
C19S
P
rhogdi2 Q61599 0.87 0.02 0.80 <0.01
C20a Stmn/1 P54227 0.84 0.19 0.70 0.01
C20b Stmn/2 P54227 0.60 0.02 0.53 0.01
C20c Stmn/3 P54227 0.88 0.14 0.76 0.01
C20S
P
Stmn P54227 0.83 0.05 0.71 0.01
C21a Sw70/1 Q6A028 1.63 0.02 1.50 0.20
C21b Sw70/2 Q6A028 2.02 0.02 1.76 0.08
C21S
P
Sw70 Q6A028 1.77 0.01 1.60 0.14
C22 Tbcb Q9D1E6 1.31 0.03 1.11 0.45
C23a Tctp/1 P63028 0.60 <0.01 0.54 <0.01
C23b Tctp/2 P63028 0.84 0.03 0.85 0.05
C23S
P
Tctp P63028 0.84 0.03 0.72 <0.01
C24a Twf1/1 Q91YR1 0.58 <0.01 0.93 0.39
Environmental Science: Nano Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
0 
Se
pt
em
be
r 2
01
9.
 D
ow
nl
oa
de
d 
on
 1
0/
10
/2
01
9 
5:
37
:2
7 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
3142 | Environ. Sci.: Nano, 2019, 6, 3133–3157 This journal is © The Royal Society of Chemistry 2019
Table 2 (continued)
Spot number Protein name Accession number Ratio acute/ctrl T test acute vs. ctrl Ratio recov/ctrl T test recov vs. ctrl
C24b Twf1/2 Q91YR1 0.25 0.01 0.86 0.52
C24S
P
Twf1 Q91YR1 0.40 <0.01 0.89 0.47
C25 Twf2 Q9Z0P5 0.70 0.01 0.60 0.01
C26 Vime P20152 1.54 0.05 1.35 0.04
C27a Vinculin/1 Q64727 1.28 0.25 1.24 0.11
C27b Vinculin/2 Q64727 1.32 0.07 1.16 0.24
C27c Vinculin/3 Q64727 1.63 0.01 1.12 0.28
C27S
P
Vinculin Q64727 1.39 0.07 1.18 0.16
D1 Cbx1 P83917 0.91 0.27 0.72 <0.01
D2a Ddb1/1 Q3U1J4 1.74 0.04 1.40 0.16
D2b Ddb1/2 Q3U1J4 0.93 0.65 0.78 0.21
D2S
P
Ddb1 Q3U1J4 1.31 0.14 1.07 0.73
D3 Nt5c Q9JM14 1.18 0.08 1.39 0.03
D4a Pcna/1 P17918 0.57 <0.01 0.57 <0.01
D4b Pcna/2 P17918 0.82 0.02 0.80 0.03
D4c Pcna/3 P17918 1.00 0.92 0.98 0.73
D4S
P
Pcna P17918 0.84 <0.01 0.82 0.02
D5 Ruvb2 Q9WTM5 1.46 0.06 1.42 0.04
E1a 6pgd/1 Q9DCD0 0.88 0.05 0.95 0.42
E1b 6pgd/2 Q9DCD0 1.05 0.32 1.01 0.90
E1S
P
6pgd Q9DCD0 0.98 0.45 0.99 0.82
E2a Aacs/1 Q9D2R0 1.79 0.11 1.39 0.52
E2b Aacs/2 Q9D2R0 3.12 0.01 2.56 <0.01
E2S
P
Aacs Q9D2R0 2.17 0.01 1.73 0.16
E3 Acadl P51174 1.13 0.14 1.27 0.01
E4a Eno1a/1 P17182 0.99 0.96 0.89 0.28
E4b Eno1a/2 P17182 1.10 0.50 0.89 0.42
E4c Eno1a/3 P17182 1.18 0.10 1.21 0.10
E4d Eno1a/4 P17182 1.50 <0.01 1.42 <0.01
E4S
P
Eno1A P17182 1.26 0.02 1.19 0.06
E5 GalK Q9R0N0 1.45 <0.01 1.50 0.03
E6 Gapdh P16858 0.56 <0.01 0.60 <0.01
E7 Gpd1L Q3ULJ0 2.27 <0.01 1.42 0.14
E8a Hxk3/1 Q3TRM8 1.91 0.02 1.80 0.03
E8b Hxk3/2 Q3TRM8 1.23 0.04 1.22 0.09
E8c Hxk3/3 Q3TRM8 1.52 0.02 1.52 0.02
E8S
P
Hxk3 Q3TRM8 1.51 0.01 1.49 0.01
E9 Idhc O88844 1.24 0.02 1.19 <0.01
E10a Ldha/1 P06151 0.79 0.02 0.86 0.06
E10b Ldha/2 P06151 0.97 0.81 0.89 0.40
E10S
P
Ldha P06151 0.89 0.26 0.88 0.21
E11a Mdhc/1 P14152 0.47 0.02 0.72 0.11
E11b Mdhc/2 P14152 0.83 0.01 0.84 0.01
E11c Mdhc/3 P14152 1.38 0.02 1.40 <0.01
E11S
P
Mdhc P14152 1.01 0.91 1.05 0.20
E12 Pckgm Q8BH04 1.30 0.20 0.61 0.01
E13 Pfkap Q9WUA3 0.84 0.01 0.86 0.01
E14 Pfkl P12382 1.83 0.01 1.62 0.03
E15a Pgls/1 Q9CQ60 0.78 0.02 0.97 0.75
E15b Pgls/2 Q9CQ60 1.11 0.16 1.22 0.01
E16 Pgp Q8CHP8 1.37 0.02 1.60 0.05
E17a Taldo1 Q93092 0.80 0.02 0.66 <0.01
E17b Taldo/2 Q93092 1.17 0.12 1.18 0.08
E17c Taldo/3 Q93092 1.24 0.02 1.23 <0.01
E17d Taldo/4 Q93092 0.81 0.06 0.79 0.02
E17e Taldo/5 Q93092 1.22 0.06 1.36 0.02
E17S
P
Taldo Q93092 1.08 0.16 1.09 0.06
E18a Tpis/1 P17751 0.74 0.01 0.82 0.04
E18b Tpis/2 P17751 1.04 0.61 1.20 0.09
E18c Tpis/3 P17751 1.45 0.04 1.43 0.05
E18S
P
Tpis P17751 1.09 0.29 1.16 0.17
F1 Cdk4 P30285 0.69 <0.01 0.71 <0.01
F2 Cdk6 Q64261 0.71 0.04 0.77 0.02
F3a Ndrg1/1 Q62433 1.32 0.09 1.52 0.04
F3b Ndrg1/2 Q62433 1.38 0.01 1.33 0.02
F3S
P
ndrg1 Q62433 1.34 0.02 1.44 0.03
F4 Pa2 g4 P50580 1.50 <0.01 1.31 0.01
Environmental Science: NanoPaper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
0 
Se
pt
em
be
r 2
01
9.
 D
ow
nl
oa
de
d 
on
 1
0/
10
/2
01
9 
5:
37
:2
7 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
Environ. Sci.: Nano, 2019, 6, 3133–3157 | 3143This journal is © The Royal Society of Chemistry 2019
Table 2 (continued)
Spot number Protein name Accession number Ratio acute/ctrl T test acute vs. ctrl Ratio recov/ctrl T test recov vs. ctrl
F5a Vma5a/1 Q99KC8 1.60 0.06 0.99 0.97
F5b Vma5a/2 Q99KC8 1.31 0.11 1.19 0.10
F5c Vma5a/3 Q99KC8 1.84 <0.01 1.59 0.02
F5S
P
Vma5a Q99KC8 1.54 0.02 1.25 0.12
G1 GalE Q8R059 0.50 0.03 1.09 0.50
G2 Gnpda1 O88958 0.47 <0.01 0.63 0.01
G3 Gt25c Q8K297 1.53 0.01 1.48 0.01
G4 Mlec Q6ZQI3 1.49 0.02 1.79 <0.01
G5a Naga/1 Q8JZV7 1.19 0.07 1.19 0.06
G5b Naga/2 Q8JZV7 1.05 0.56 1.18 0.08
G5S
P
Naga Q8JZV7 1.12 0.16 1.19 0.06
H1 Adh5 P28474 0.72 0.09 0.74 0.11
H2a Aldr/1 P45376 0.57 0.01 0.66 0.01
H2b Aldr/2 P45376 0.84 0.09 0.73 0.04
H2c Aldr/3 P45376 1.18 0.04 1.25 0.01
H2S
P
Aldr P45376 0.85 0.02 0.89 0.10
H3 Aldr2 P47738 1.16 0.08 1.23 <0.01
H4a Bvra/1 Q9CY64 0.54 0.02 0.62 0.03
H4b Bvra/2 Q9CY64 1.23 0.08 1.30 0.06
H4S
P
Bvra Q9CY64 0.98 0.81 1.06 0.54
H5 Bvrb Q923D2 1.45 0.01 0.96 0.77
H6 Ca13 Q9D6N1 0.62 0.01 0.83 0.11
H7a Esd/1 Q9R0P3 0.56 <0.01 0.64 0.01
H7b Esd/2 Q9R0P3 0.78 <0.01 0.92 0.15
H7S
P
Esd Q9R0P3 0.73 <0.01 0.86 0.02
H8 Frih P09528 0.61 0.01 0.67 0.02
H9 Gclm O09172 1.32 0.01 0.98 0.86
H10 Hmox2 O70252 1.53 <0.01 1.03 0.69
H11a Lgul/1 Q9CPU0 0.80 0.04 0.77 0.05
H11b Lgul/2 Q9CPU0 1.10 0.24 1.10 0.16
H11S
P
Lgul Q9CPU0 1.00 0.99 1.00 0.96
L1 Anxa1 P10107 0.78 0.02 1.11 0.06
L2a Anxa2/1 P07356 0.79 0.01 0.60 <0.01
L2b Anxa2/2 P07356 0.44 <0.01 0.56 <0.01
L2S
P
Anxa2 P07356 0.67 <0.01 0.59 <0.01
L3 Anxa3 O35639 1.34 0.01 1.30 0.02
L4 Anxa4 P97429 1.30 0.01 1.33 <0.01
L5a Anxa5/1 P48036 0.88 0.02 0.81 <0.01
L5b Anxa5/2 P48036 1.09 0.34 1.07 0.37
L5S
P
Anxa5 P48036 0.95 0.35 0.90 0.08
L6 Anxa6 P14824 1.54 0.02 1.80 <0.01
L7 Anxa7 Q07076 1.14 0.44 1.57 0.02
L8 Idi1 P58044 1.40 0.02 1.34 0.01
L9 Lypla2 Q9WTL7 1.07 0.28 1.22 0.02
L10 Mbd3 Q9Z2D8 1.52 0.02 1.77 <0.01
L11 Pipna P53810 1.22 0.11 1.32 0.01
L12 Ppt1 O88531 1.24 0.14 1.34 0.03
M1a Clic4/1 Q9QYB1 0.90 0.12 0.95 0.58
M1b Clic4/2 Q9QYB1 1.27 0.02 1.27 0.04
M1S
P
Clic4 Q9QYB1 1.12 0.04 1.14 0.01
M2 Clybl Q8R4N0 1.80 0.03 1.41 0.19
M3 Gatm Q9D964 0.68 0.01 0.54 0.01
M4 Hmgcl P38060 0.61 <0.01 0.76 0.07
M5 Nduv2 Q9D6J6 1.24 0.01 1.49 0.05
M6 Oat P29758 1.30 0.05 1.50 0.01
M7 Odba P50136 1.54 0.02 1.28 0.12
M8 Phb P67778 1.12 0.16 1.18 0.05
M9 Tmem11 Q8BK08 1.78 0.04 1.46 0.41
M10 Vdac2 Q60930 0.63 0.02 0.72 0.05
M11a Atpb ac P56480 1.23 0.16 1.41 0.03
M11b Atpb bas P56480 1.60 0.04 1.58 <0.01
M11S
P
Atpb P56480 1.41 0.06 1.49 <0.01
M12 Clpp O88696 1.28 0.33 1.84 0.02
M13a Trap1/1 Q9CQN1 1.74 0.02 1.32 0.13
M13b Trap1/2 Q9CQN1 1.21 0.25 0.92 0.64
M13S
P
Trap1 Q9CQN1 1.47 0.03 1.11 0.51
N1a Aprt/1 P08030 0.52 <0.01 0.72 <0.01
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Table 2 (continued)
Spot number Protein name Accession number Ratio acute/ctrl T test acute vs. ctrl Ratio recov/ctrl T test recov vs. ctrl
N1b Aprt/2 P08030 1.06 0.43 1.08 0.39
N1S
P
Aprt P08030 0.92 0.19 0.99 0.85
N2 Bpnt1 Q9Z0S1 1.77 0.02 1.87 0.01
N3 Guaa Q3THK7 1.42 0.02 1.12 0.25
N4 Hint1 P70349 1.46 0.30 0.64 0.02
N5 Ndka P15532 0.42 0.03 0.75 0.22
N6 Paps1 Q60967 5.54 0.04 2.44 0.01
N7a Pnph/1 P23492 0.83 0.12 0.72 0.05
N7b Pnph/2 P23492 1.25 0.02 1.22 0.08
N7S
P
Pnph P23492 1.08 0.17 1.02 0.76
N8a Prps1/1 Q9D7G0 0.69 0.01 0.92 0.48
N8b Prps1/2 Q9D7G0 0.57 <0.01 0.77 0.16
N8c Prps1/3 Q9D7G0 0.52 0.01 0.83 0.21
N8S
P
Prps1 Q9D7G0 0.60 <0.01 0.83 0.14
N9a Pur4/1 Q5SUR0 1.71 0.14 1.27 0.07
N9b Pur4/2 Q5SUR0 2.53 0.01 2.01 0.01
N9c Pur4/3 Q5SUR0 1.15 0.53 1.25 0.22
N9S
P
Pur4 Q5SUR0 1.65 0.07 1.43 0.01
N10 Pur9 Q9CWJ9 1.16 0.27 1.23 0.01
N11 Nt5c3b Q3UFY7 1.55 <0.01 1.64 0.01
O1 Prx1ox P35700 0.58 0.02 0.70 0.04
O2a Prx3/1 P20108 0.93 0.69 1.13 0.08
O2b Prx3/2 P20108 1.23 0.06 1.32 0.01
O2S
P
Prx3 P20108 1.16 0.22 1.27 0.01
O3 Prx4 O08807 0.75 0.06 0.56 0.01
O4a Prx6/1 O08709 0.56 0.02 0.45 0.01
O4b Prx6/2 O08709 1.05 0.64 0.97 0.76
O4S
P
Prx6 O08709 0.96 0.63 0.87 0.23
P1 Aars Q8BGQ7 1.65 0.01 1.18 0.20
P2a Eef2/1 P58252 0.77 0.02 0.63 <0.01
P2b Eef2/2 P58252 1.06 0.41 0.96 0.39
P2c Eef2/3 P58252 0.84 0.07 0.90 0.20
P2d Eef2/4 P58252 0.99 0.88 0.98 0.61
P2e Eef2/5 P58252 1.39 0.01 1.29 0.01
P2S
P
Eef2 P58252 1.02 0.72 0.97 0.43
P3 If3g Q9Z1D1 0.77 0.31 0.56 0.03
P4a If5a/1 P63242 0.54 <0.01 0.62 <0.01
P4d If5a/2 P63242 1.07 0.26 1.03 0.58
P4S
P
If5a P63242 0.86 0.04 0.87 0.04
P5 If4a1 P60843 1.55 0.01 1.51 0.01
P6 If4a3 Q91VC3 1.27 0.05 1.09 0.28
P7 Rla0 P14869 1.28 0.07 1.33 0.04
P8 Rs4y1 P62702 0.50 0.04 0.62 0.07
P9a Sars/1 P26638 1.42 0.03 1.05 0.59
P9b Sars/2 P26638 1.52 0.04 1.10 0.42
P9S
P
Sars P26638 1.48 0.02 1.08 0.46
Q1a Dpp3/1 Q99KK7 1.28 0.22 1.75 <0.01
Q1b Dpp3/2 Q99KK7 1.55 0.04 1.84 <0.01
Q1S
P
Dpp3 Q99KK7 1.40 0.09 1.79 <0.01
Q2a Hsp74/1 Q61316 0.77 0.22 0.77 0.23
Q2b Hsp74/2 Q61316 1.33 0.08 1.18 0.23
Q2c Hsp74/3 Q61316 1.31 0.09 1.14 0.29
Q2d Hsp74/4 Q61316 1.26 0.15 1.31 <0.01
Q2S
P
Hsp74 Q61316 1.07 0.58 1.03 0.80
Q3a Hyou1/1 Q9JKR6 1.18 0.25 0.83 0.20
Q3b Hyou1/2 Q9JKR6 1.38 0.01 1.18 0.03
Q3c Hyou1/3 Q9JKR6 1.35 0.01 1.21 0.05
Q3d Hyou1/4 Q9JKR6 0.80 0.23 0.79 0.11
Q3S
P
Hyou1 Q9JKR6 1.04 0.67 0.93 0.27
Q4 Lxn P70202 0.98 0.80 1.26 <0.01
Q5 Pfd2 O70591 0.72 0.01 0.70 0.01
Q6a Ppce/1 Q9QUR6 1.40 0.15 1.78 0.01
Q6b Ppce/2 Q9QUR6 1.58 0.04 1.66 0.01
Q6S
P
Ppce Q9QUR6 1.50 0.07 1.71 0.01
Q7a Ppia/1 P17742 0.68 0.11 0.57 0.05
Q7b Ppia/2 P17742 0.80 0.21 0.79 0.21
Q7c Ppia/3 P17742 0.81 0.09 0.99 0.97
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Table 2 (continued)
Spot number Protein name Accession number Ratio acute/ctrl T test acute vs. ctrl Ratio recov/ctrl T test recov vs. ctrl
Q7S
P
Ppia P17742 0.78 0.09 0.83 0.21
Q8a Spb6/1 Q60854 1.66 0.02 1.49 0.01
Q8b Spb6/2 Q60854 1.43 0.01 1.42 0.01
Q8S
P
Spb6 Q60854 1.57 0.01 1.46 <0.01
Q9 Stip1 Q60864 1.72 <0.01 0.94 0.67
Q10 Tcpa P11983 1.55 0.02 1.09 0.55
R1a Btf3/1 Q64152 0.56 0.01 0.50 0.01
R1b Btf3/2 Q64152 0.76 0.05 0.76 0.05
R1S
P
Btf3 Q64152 0.66 0.02 0.64 0.01
R2 Dcps Q9DAR7 1.30 <0.01 1.20 0.02
R3 Ddx39a Q8VDW0 1.64 0.03 1.31 0.02
R4 Ddx39b Q9Z1N5 1.59 0.03 1.35 0.11
R5 Mgn P61327 0.96 0.60 0.56 0.01
R6a Sf3b2/1 Q3UJB0 1.03 0.91 0.87 0.49
R6b Sf3b2/2 Q3UJB0 1.16 0.44 1.32 <0.01
R6c Sf3b2/3 Q3UJB0 1.26 0.38 1.80 <0.01
R6S
P
Sf3b2 Q3UJB0 1.13 0.54 1.27 0.03
R7 ExoS4 Q921I9 0.88 0.42 0.51 0.02
R8 ExoS6 Q8BTW3 1.50 0.02 1.53 0.01
S1a 14-3-3 gam/1 P61982 0.85 0.28 0.67 0.02
S1b 14-3-3 gam/2 P61982 0.83 0.06 0.91 0.24
S1S
P
14-3-3 gam P61982 0.84 0.10 0.82 0.07
S2 14-3-3 th P68254 1.31 0.01 1.19 0.04
S3 Cab39 Q06138 0.70 0.03 0.62 <0.01
S4 Fam49b Q921M7 1.47 0.02 1.59 0.05
S5 Gbb1 P62874 1.17 0.03 1.18 0.03
S6a Gnai2/1 P08752 1.33 0.06 1.42 0.05
S6b Gnai2/2 P08752 1.51 <0.01 1.67 0.01
S6S
P
Gnai2 P08752 1.45 0.01 1.59 0.02
S7 Gnb2L1 P68040 0.89 0.02 0.81 <0.01
S8 Grb2 Q60631 1.06 0.83 1.46 0.02
S9 Igbp1 Q61249 1.36 0.06 1.36 0.04
S10 In35 Q9D8C4 1.25 0.04 1.21 0.14
S11 Inpp P49442 2.46 0.01 1.76 0.17
S12 Ppp1ca P62137 1.17 0.07 1.27 0.02
S13a Ppp1r7/1 Q3UM45 0.30 0.02 0.38 0.04
S13b Ppp1r7/2 Q3UM45 0.67 0.02 0.73 0.08
S13c Ppp1r7/3 Q3UM45 0.90 0.51 0.94 0.72
S13S
P
Ppp1r7 Q3UM45 0.61 0.03 0.68 0.06
S14 Ppp6 O00743 1.48 0.03 1.04 0.82
S15a Snd1/1 Q78PY7 0.65 0.03 0.66 0.04
S15b Snd1/2 Q78PY7 0.59 0.02 0.50 0.01
S15c Snd1/3 Q78PY7 0.89 0.34 0.78 0.18
S15d Snd1/4 Q78PY7 1.11 0.34 0.91 0.47
S15S
P
Snd1 Q78PY7 0.79 <0.01 0.70 0.01
U1 Chip Q9WUD1 0.59 <0.01 0.73 0.11
U2 Csn4 O88544 1.34 0.03 1.37 0.03
U3a Prs8/1 P62196 0.60 <0.01 0.65 <0.01
U3b Prs8/2 P62196 0.85 0.04 0.85 0.22
U3S
P
Prs8 P62196 0.31 0.33 0.32 0.34
U4a Psa2/1 P49722 0.58 <0.01 0.58 <0.01
U4b Psa2/2 P49722 1.15 0.12 1.28 0.07
U4S
P
Psa2 P49722 0.86 0.04 0.92 0.36
U5a Psa5/1 Q9Z2U1 0.80 0.01 0.84 0.11
U5b Psa5/2 Q9Z2U1 0.92 0.33 0.99 0.83
U5S
P
Psa5 Q9Z2U1 0.86 0.07 0.92 0.22
U6 Psb10 O35955 0.73 0.12 0.43 0.02
U7a Psb2/1 Q9R1P3 0.67 0.02 0.76 0.14
U7b Psb2/2 Q9R1P3 0.90 0.36 1.01 0.91
U7S
P
Psb2 Q9R1P3 0.82 0.09 0.92 0.50
U8 Psb3 mod Q9R1P1 0.47 0.01 0.65 <0.01
U9a Psb4/1 P99026 0.74 0.05 0.69 0.03
U9b Psb4/2 P99026 0.98 0.71 0.94 0.25
U9S
P
Psb4 P99026 0.90 0.05 0.86 0.01
U10 Psmd14 O35593 1.03 0.61 1.32 <0.01
U11a Psmd2/1 Q8VDM4 0.82 0.22 1.12 0.24
U11b Psmd2/2 Q8VDM4 1.10 0.11 1.09 0.02
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which is known to be up-regulated by acetylation.71 In our
case, the activity correlated with the amount of the acidic,
modified spots and not with the total amount of the protein.
For other activities, e.g. lactate dehydrogenase, triose phos-
phate isomerase and purine phosphorylase, the activity corre-
lated with the total protein amount and not with a single
spot. For several other enzymes such as enolase, hexokinase,
pyridoxal kinase and isocitrate dehydrogenase, we detected
an increase of the protein amount by proteomics and a stable
or decreased enzyme activity.
3.5 Mitochondrial potential and glucose consumption
Several mitochondrial proteins appeared modulated upon ex-
posure of macrophages to silver nanoparticles, among which
are a few subunits of the respiratory complexes (NDUV2 and
ATPB), some components of the mitochondrial protein qual-
ity control (TRAP1 and CLPP) and an antioxidant protein
(PRX3). As this may suggest perturbations in the mitochon-
drial functions, we investigated the mitochondrial transmem-
brane potential. The results, shown in Fig. 5, indicated that
all viable cells accumulated rhodamine 123 and thus had a
strong mitochondrial transmembrane potential. However, the
amount of accumulated rhodamine 123 and thus the level of
the mitochondrial transmembrane potential were lower for
the acute condition and went back to normal after 72 hours
of recovery. As a lower transmembrane potential is indicative
of a less efficient oxidative phosphorylation chain, we investi-
gated the global metabolism under the three experimental
conditions.
We thus measured the glucose consumption during the
last 36 hours of the experiments by measuring the remaining
glucose in the culture medium at the end of the experiment.
The initial medium contained 4.1 g of glucose per liter due
Table 2 (continued)
Spot number Protein name Accession number Ratio acute/ctrl T test acute vs. ctrl Ratio recov/ctrl T test recov vs. ctrl
U11c Psmd2/3 Q8VDM4 1.39 0.02 1.13 0.17
U11S
P
Psmd2 Q8VDM4 1.03 0.70 1.12 0.12
U12 Psmd7 P26516 0.68 0.03 0.68 0.02
U13 Psme1 P97371 1.40 <0.01 1.40 <0.01
U14a Psme2/1 P97372 1.00 0.98 0.71 <0.01
U14b Psme2/2 P97372 1.22 <0.01 1.07 0.34
U14S
P
Psme2 P97372 1.15 <0.01 0.96 0.50
U15 Ubl7 Q91W67 0.41 0.02 0.88 0.55
V1 Asna1 O54984 1.29 0.09 1.46 <0.01
V2 Chm2a Q9DB34 0.83 <0.01 0.92 0.09
V3 CopE O89079 1.35 0.01 1.41 0.07
V4 Emc2 Q9CRD2 0.56 0.01 0.84 0.07
V5 Erp29 P57759 0.78 0.12 0.68 0.05
V6 Mss4 Q91X96 0.52 0.04 0.64 0.10
V7 Nsf1c Q9CZ44 1.55 0.01 1.51 0.01
V8 Pef1 Q8BFY6 0.64 0.05 0.50 0.02
V9 Snaa Q9DB05 1.53 <0.01 1.99 0.05
V10 Snap23 O09044 0.53 0.02 0.34 0.01
V11 Stxb2 Q64324 2.07 <0.01 1.30 0.09
V12a Tera/1 Q01853 1.31 0.13 1.18 0.16
V12b Tera/2 Q01853 1.49 0.02 1.06 0.38
V12c Tera/3 Q01853 1.39 0.02 1.29 0.04
V12d Tera/4 Q01853 1.48 0.10 1.35 <0.01
V12S
P
Tera Q01853 1.43 0.02 1.25 0.01
V13 Tpd52 Q62393 1.42 0.04 1.31 0.10
V14 Vat1 Q62465 1.48 0.01 1.22 0.15
V15 Vps29 Q9QZ88 1.30 0.05 1.29 0.08
V16a Vps35/1 Q9EQH3 2.44 0.16 2.33 <0.01
V16b Vps35/2 Q9EQH3 1.80 0.17 2.03 0.01
V16c Vps35/3 Q9EQH3 1.53 0.33 2.25 <0.01
V16S
P
Vps35 Q9EQH3 1.79 0.18 2.20 <0.01
V17 Vta1 Q9CR26 2.84 0.01 2.97 0.02
X1 Pdxk Q8K183 1.29 <0.01 1.45 0.02
X2 Spee Q64674 1.55 0.02 1.43 0.07
X3 Sps1 Q8BH69 1.49 0.02 1.95 0.01
X4a Ran/1 P62827| 0.83 0.04 0.87 0.12
X4b Ran/2 P62827| 1.18 0.08 1.11 0.17
X4S
P
Ran P62827| 1.03 0.62 1.00 0.98
Y1 CatD P18242 1.38 0.01 1.48 <0.01
Y2 CatZ Q9WUU7 1.79 0.04 1.08 0.85
Y3 Ncf4 P97369 1.15 0.02 1.19 0.01
P
: sum of the different spots identified for the same protein.
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to the dilution brought by the addition of fetal serum to ob-
tain the complete medium. In the untreated, control cells,
1.8 ± 0.2 g of glucose per liter remained in the culture medium
after 36 hours of culture. In contrast, 1 ± 0.05 g of glucose and
0.9 ± 0.04 g of glucose remained in the medium for the acute
and recovery conditions, respectively. These differences were
statistically significant (Mann Whitney U test, p < 0.05).
The increased glucose consumption in the acute exposure
condition could be correlated with the less efficient mito-
chondria via a Warburg effect. However, this correlation did
not hold for the recovery condition, in which the mitochon-
dria appear as efficient as those of the control cells. This may
suggest that the silver expulsion process that takes place dur-
ing the recovery period consumes a lot of energy.
3.6 Glutathione levels
One of the proteins that is induced after acute exposure to
silver nanoparticles is GCLM, i.e. the regulatory subunit of
the enzyme involved in the first step of glutathione biosyn-
thesis, which is the limiting step of the pathway.72 We thus
investigated the levels of free glutathione, as studies on pri-
mary macrophages had shown that treatment with silver
nanoparticles decreased the levels of free glutathione.23 This
result may be due to the formation of silver–glutathione com-
plexes.73 We thus measured by flow cytometry the proportion
of cells with high levels of reduced glutathione, and the level
of glutathione in this population. The results, shown in
Fig. 6, indicated that the glutathione level is only 70% of the
normal one just after the exposure to silver nanoparticles,
and is 85% of the normal after 3 days of recovery. Thus, here
again, the increase in GCLM amount can be interpreted as a
cellular mechanism to compensate for the decrease of free
glutathione caused by silver.
3.7 Actin cytoskeleton and phagocytosis
Cytoskeletal proteins, especially proteins implicated in the actin
cytoskeleton dynamics, were among the most important classes
emerging from the proteomic screen. Of note, many of these
proteins have activities that are modulated by phosphorylation,
such as cofilin74,75 or Rho-GDIs.76,77 As the regulation patterns
Fig. 4 Proteomic analysis of total cell extracts by 2D electrophoresis.
Total cell extracts of RAW274.7 cells were separated by two-dimensional
gel electrophoresis. The first dimension covered a 4–8 pH range and the
second dimension a 15–200 kDa range. Total cellular proteins (150 μg)
were loaded on the first dimension gel. A: Gel obtained from control
cells. B: Gel obtained from cells treated for 24 hours with 20 μg ml−1 sil-
ver nanoparticles. C: Gel obtained from cells treated for 24 hours with
20 μg ml−1 silver nanoparticles and left to recover for 72 hours. Only the
proteins involved in apoptosis (A), energy metabolism (E) and control of
cell fate and proliferation (F) are shown in this figure.
Table 3 Enzyme activities
Enzyme Control Acute Recov Ctrl + silver ion
LDH 74.4 ± 2.75 68.9 ± 1.14* 73.8 ± 4.13 ND
MDH 37.4 ± 0.95 31.3 ± 2.85* 31.7 ± 2.36* ND
TPIS 70.7 ± 8.75 76.6 ± 5.58 76.3 ± 7.80 ND
BVR 0.67 ± 0.04 0.53 ± 0.1* 0.79 ± 0.06* ND
PDXK 7.4 ± 0.95 5.9 ± 0.6* 7.5 ± 0.68* ND
GAPDH 157.12 ± 14.5 144.25 ± 9.77 157.44 ± 5.91 ND
6PGDH 30.69 ± 3.17 39.37 ± 4.92* 38.75 ± 1.24* ND
PNPH 8.97 ± 1.17 9.12 ± 1.6 9.06 ± 0.77 ND
HXK 23.4 ± 3.04 16.3 ± 4* 23.3 ± 2.45 (1 μM) 14.2 ± 2.93
ENO 214.5 ± 13.6 166.4 ± 28.1* 184 ± 41 (10 μM) 167 ± 12.4
IDHC 16.37 ± 1.48 17.62 ± 2.79 23.75 ± 2.97** (5 μM) 8.06 ± 1.09
All the activities are expressed in nmol substrate converted per min per mg total protein. Statistical significance of the results in the Student T
test: *p < 0.05. ND: not determined. Abbreviations: LDH: lactate dehydrogenase; MDH: malate dehydrogenase; TPIS: triose phosphate
isomerase; BVR: biliverdine reductase; PDXK: pyridoxal kinase; GAPDH: glyceraldehyde phosphate dehydrogenase; 6PGDH: 6-phosphogluconate
dehydrogenase; PNPH: purine nucleoside phosphorylase; HXK: hexokinase; ENO: enolase; IDHC: NADPH-dependent isocitrate dehydrogenase.
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that emerged from the proteomic screen for these proteins were
very complex, with some spots modulated while others were
constant, we directly examined the consequences on the actin
cytoskeleton. The results, shown in Fig. 7, indicated a strong
vesicularization of the cells during the recovery period.
Phagocytosis is one of the specialized functions of the
macrophages that is highly dependent on the actin cytoskele-
ton. We thus tested the phagocytic activity of the cells. The
results, shown in Fig. 8, indicated that the proportion of
phagocytic cells does not change upon treatment with silver
nanoparticles. However, the number of internalized particles
per cell, as described by the mean fluorescence, slightly de-
creased immediately after exposure to nanoparticles and
went back to quasi-normal values after 72 hours of recovery.
3.8 NO and cytokine production, redox balance
Production of nitric oxide and pro-inflammatory cytokines
such as IL-6 and TNF upon stimulation is another specialized
function of macrophages. We thus investigated their produc-
tion after treatment of macrophages with silver nanoparticles
under two schemes: either after treatment with nanoparticles
only, or after treatment with nanoparticles and lipopolysac-
charide (LPS) for the last 24 hours of culture. The first
scheme investigated the intrinsic pro-inflammatory action of
the nanoparticles, while the second one investigated the
interference of nanoparticles with a standard pro-
inflammatory response induced by a bacterial stimulus. The
results, shown in Fig. 9, indicated that silver nanoparticles
have a weak but significant intrinsic pro-inflammatory effect,
as detected from NO and TNF production, which returned to
normal values after the recovery period. The situation was
however very different for the combined nanoparticle–LPS
treatment. In this case, the acute exposure condition did not
differ significantly from the control cells (exposed to LPS
only), while the cytokine and NO production were signifi-
cantly lower after the recovery period. As the NO production
Fig. 5 Mitochondrial transmembrane potential analysis. The rhodamine 123 accumulation method was used. Panel A: Proportion of rhodamine123-
positive cells in the viable cell population. Panel B: Mean rhodamine 123 fluorescence (in the viable cell population only). Symbols indicate the statis-
tical significance (Student's T-test): *: p < 0.05. ctrl: Non exposed cells. acute: Cells exposed for 24 hours to silver nanoparticles (20 μg ml−1). recov:
Recovering cells (72 hours post exposure to silver nanoparticles). Symbols indicate the statistical significance (Student's T-test): *: p < 0.05.
Fig. 6 Free glutathione levels. The chlorobimane (mCB) conjugation method was used. Panel A: Proportion of GSH-positive cells in the viable cell
population. Panel B: Mean GSH-mCB conjugate fluorescence (in the viable cell population only). Symbols indicate the statistical significance (Stu-
dent's T-test): ***: p < 0.001. ctrl: Non exposed cells. acute: Cells exposed for 24 hours to silver nanoparticles (20 μg ml−1). recov: Recovering cells
(72 hours post exposure to silver nanoparticles).
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is NADPH-dependent, we investigated the NADP–NADPH
levels after treatment with nanoparticles. The results, shown
in Table 4, indicated that both the total NADP + NADPH and
NADPH levels were similar for the three conditions tested.
4. Discussion
Silver nanoparticles are usually produced through a wet route
and need to be stabilized as soon as prepared to avoid irre-
versible aggregation. Stabilization of AGNPs is usually
achieved through interaction with complex ions such as cit-
rate, or by polymers such as polyethylene glycol or poly-
vinylpyrrolidone (PVP). As such, PVP-coated silver nano-
particles are industrial products used in several applications
including as antibacterial compounds,78 conductive inks,79–81
and sensors,82 and in electromechanics.83 In the course of
their use, nanoparticles can be aerosolized. In this case they
can contaminate living organisms without being modified. In
the specific case of inhalation contamination, the nano-
particles reach the alveolae where there will be internalized
by the lung macrophages, which is the reason why we made
the choice to use this cell type in this study. Regarding other
environmental dispersion routes, PVP-coated silver nano-
particles have been shown to be the most resistant in fresh-
water environments,84 and thus recommended for ecotoxico-
logical testing.84 The PVP-coated silver nanoparticles,
therefore, appear to be relevant for assessing the toxicity of
silver nanoparticles.
Most of the toxicological studies on nanoparticles use an
acute exposure scheme; they expose cells to a high, but non-
lethal dose. Such a scheme does not represent chronic daily
exposure under, for example, occupational conditions, but
may represent the dose following an accidental exposure. To
fully evaluate the toxicity of AgNPs, it is therefore important
to know not only the acute effects post exposure, but also
how cells recover from such exposures to high dosages of
AgNPs. To accomplish this, a ternary comparison must be
made between cells before and immediately after treatment
and also between cells at the end of a recovery period. In this
experimental frame, the acute exposure point is not the pri-
mary focus of attention. We therefore decided not to investi-
gate in detail the role of silver ions in the acute response,
based on the fact that the rather large silver nanoparticles
used in this study dissolve to a very low extent,23 producing
free silver ion concentrations that are far below the LD20 ob-
served for silver ions. Furthermore, this aspect has been in-
vestigated in numerous studies (e.g. in ref. 8, 15, 59 and 85)
and the general outcome of these studies is that the mecha-
nisms observed for silver nanoparticles cannot be explained
by silver ions, at least for large nanoparticles.15
In this frame, the proteomic approach is of interest be-
cause it can be used to explore not only a few parameters, as
Fig. 7 Confocal imaging of the F-actin cytoskeleton. Only one confo-
cal plane inside the cells is shown (going through the cell nucleus). A:
Unexposed cells. B: Acutely-exposed cells. C: Recovering cells. Silver-
treated cells show an important vesicularization, compatible with the
presence of nanoparticles within the cell phagosomes.
Fig. 8 Phagocytosis. The phagocytic capacity was assessed by fluorescent latex bead internalization. Panel A: Proportion of positive cells in the
viable cell population. Panel B: Mean cellular fluorescence (in the viable cell population only). ctrl: Non exposed cells. acute: Cells exposed for 24
hours to silver nanoparticles (20 μg ml−1). recov: Recovering cells (72 hours post exposure to silver nanoparticles).
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targeted approaches do, but also can be used to investigate a
few hundred parameters at the same time, i.e. the abun-
dances of the various proteins analyzed in a proteomic
screen. In this respect, the use of a 2D gel-based proteomic
approach may appear as a medium scale approach, compared
to deep shotgun proteomic approaches. However, compared
to shotgun proteomics, 2D gels have the unique ability to
separate protein forms, without the requirement that they ap-
pear as a single product. With growing recognition of the im-
portance of post-translational modifications, the ability to do
this is biologically relevant. Indeed, we have shown both in
this study and in previous ones53,86 that some enzyme activi-
ties correlate with a single protein form and not with the
sum of all the protein forms, showing the relevance of this
parameter.
First, we performed a global analysis of the proteomic re-
sults. Both the principal component analysis and the analysis
of similarity (ANOSIM) indicated that the recovery state was
Fig. 9 NO and cytokine production. NO, TNF-alpha and IL-6 production were measured under the different cell culture conditions, with and with-
out further exposure to LPS. ctrl: Non exposed cells. acute: cells exposed for 24 hours to silver nanoparticles (20 μg ml−1). recov: Recovering cells
(72 hours post exposure to silver nanoparticles). Symbols indicate the statistical significance (Student's T-test): *: p < 0.05 ; **: p < 0.01 ; ***: p <
0.001. A and B: NO production, without (panel A) and with (panel B) exposure to LPS. C and D: TNF-alpha production, without (panel C) and with
(panel D) exposure to LPS. E: IL-6 production with exposure to LPS. IL-6 is undetectable under the three culture conditions tested when the cells
are not exposed to LPS.
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not just an intermediate state between the unexposed cells
and the acutely-exposed cells. If this were the case, the recov-
ery state should not have been separated from the other two
states as it is in the principal component analysis. This is fur-
ther confirmed by ANOSIM. The fact that all the p-values in
the binary comparison are low and rather similar shows that
the three states are significantly different from each other. If
the recovery stage was just between the other two stages, at
least one of the p-values between the recovery stage and one
of the other two stages should be much higher than the
p-value between the control and the acute stage. As this is
not the case, we can reject the hypothesis that the recovery
phase is only an intermediate between the control and
acutely-treated stages.
We then performed a more detailed analysis of the proteo-
mic results. The first important challenge was to determine
to what extent the changes observed through proteomics are
specific to silver nanoparticles and which are due to the sim-
ple presence of a PVP-coated nanoparticle. We have
addressed this question in previously published studies.35,53
In these studies, we showed that PVP-coated zirconium oxide
nanoparticles induced minimal changes at the proteomic
level. This ruled out the possibility that the changes that we
observe in the present study could be due either to the inter-
nalization process per se or are due to the effect of the addi-
tion of PVP.
As a further step, we compared our results obtained im-
mediately after exposure to those published in the litera-
ture.9,10,24 It should be noted that this comparison is chal-
lenging because these other studies did not use the same cell
type as was used here (although two of them use human in-
testinal cell lines, however different ones9,24) or the same sil-
ver nanoparticles. Citrate-coated silver nanoparticles were
used in one study,24 while the other two used surfactant-
coated nanoparticles,9,10 and in this study PVP-coated nano-
particles were used. These differences are very likely to ex-
plain the wide differences observed between the studies in
which proteins were differentially modulated by treatment,
with a minimal overlap between the results. Despite this gen-
eral trend, several convergences could be observed between
our study and those previously published. For example, in-
creases in the abundances of Ran, Moesin, RuvB2, EfhD2,
Pfkl, Anxa3, Tcpa and Tbcb were observed both in our study
and the one published by Verano-Braga et al.24
However, proteomics is prone to multiple testing issues,
so that the results obtained by proteomics must be verified
by independent, targeted experiments. To accomplish this,
we analyzed enzyme activities. Our enzyme activity results
were consistent with observations made about changes at the
proteomic level. However, a few discrepancies occurred,
which were always of the same type: increases in the protein
level by proteomics, corresponding to stable or decreased ac-
tivities. We could, however, show that these enzyme activities
are very sensitive to the silver ion, which was released within
cells during their exposure to silver nanoparticles. Thus, the
increase in protein levels can be seen in such cases as a cellu-
lar mechanism to compensate for the decrease of activity
brought by silver.
We then carried out indirect validation studies, for exam-
ple on the free glutathione levels, which were decreased im-
mediately after exposure, a phenomenon that was previously
observed for copper nanopartlcles.35 We also tested phagocy-
tosis, which is an important function of macrophages and is
important for clearing bacteria. For this assay we used
micron-sized fluorescent beads, which functioned as bacterial
mimics. This allowed us to investigate whether nanoparticle-
treated cells were still able to clear bacteria. The proteomic
screen suggested that phagocytosis might be altered after
treatment with silver nanoparticles, which was confirmed in
our assay testing the ability of the cell to clear bacteria. These
results were previously observed for primary macrophages.23
The key question asked in this study, however, does not
revolve around the acute response to silver nanoparticles, but
instead asks to what extent and by which means do cells re-
cover after such an exposure. In a simple model for recovery,
protein changes should exhibit trends that return to normal,
i.e. the amplitude of the change in abundance between the
recovery and control stages should be lower than the ampli-
tude of the change in abundance between the acute exposure
and control stages. Out of the 239 spots that are highlighted
in the proteomic screen, 135 (56%) show such a trend. This
means that 104 (44%) show a stronger response at the recov-
ery phase than immediately after exposure. With such a split
trend, it is interesting to evaluate the results of targeted ex-
periments during the recovery phase.
Interestingly, this split trend was also apparent in the re-
sults of targeted experiments. General metabolic processes
seem to return to normal (mitochondrial potential, glutathi-
one levels, and most enzymatic activities), as well as phagocy-
tosis and basal NO production (without LPS stimulation). Op-
positely, the LPS-induced activities (e.g. NO, IL-6 and TNF
production) worsen during the recovery phase, as well as the
isocitrate dehydrogenase activity, and the glucose consump-
tion, which stays much higher at both the recovery and acute
exposure phases than in unexposed cells.
It was the necessary to check in detail how proteomic
changes correlate with observed functional changes. For ex-
ample, for mitochondrial proteins, the proteomic screen de-
tects an increase in the beta subunit of ATP synthase (ATPB)
and an increase in one subunit of respiratory complex I
(NDUV2) upon cell exposure to silver nanoparticles. At the
same time the mitochondrial transmembrane potential
Table 4 NADP(H) concentrations in cells
Ctrl Acute Recov
NADPH 1.87 ± 0.12 1.88 ± 0.03 1.85 ± 0.01
NADP + NADPH 2.5 ± 0.09 2.33 ± 0.04 2.62 ± 0.06
NADPH/(NADP + NADPH) 0.75 ± 0.07 0.81 ± 0.02 0.71 ± 0.02
All the concentrations are expressed in nmol nucleotide per mg total
protein.
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decreases slightly, showing that this increase in mitochon-
drial proteins could be an attempt to restore normal energy
production in cells. Upon recovery, one of the ATPB spots
slightly decreases compared to the value immediately after
exposure, while the other spot further increases. The NDUV2
spot is also enhanced. However, even the ATPB spot that de-
creased is still significantly more abundant at this stage of re-
covery than in control cells. This shows that the cellular situ-
ation is still not back to normal, as can be expected from the
still high intracellular silver content, and that restoring the
metabolic activity of a cell is an active process requiring an
upregulation of several proteins.
Opposite to the delayed return to control values, GCLM,
for example, shows an increase just after exposure. When the
glutathione demand is high and the free glutathione levels
are low, there is a return to control values at the end of the
recovery period, at which point free glutathione levels are
close to normal again.
In contrast to this simple case, the regulation of the actin
cytoskeleton is much more complex. Many of the proteins
interacting with actin and regulating its dynamics are regu-
lated by phosphorylation. This holds true for cofilin,74
actinin 4,87 vinculin,88 swap70,89 arpc5,90 gelsolin91 and
Arp2.92 While this further demonstrates the interest of taking
into account modified protein forms, there are no obvious
rules to predict which modified spot(s) is (are) effectorĲs) on
the actin cytoskeleton. For example, the effector spot for
cofilin is the median spot.93 Consistent with what has been
described in the literature, we observe mostly modulations
on acidic, modified forms of the above-cited proteins.
In line with the sustained changes in the actin cytoskele-
ton observed even at the recovery stage, we observe sustained
changes in these modified spots, as exemplified by spots 2 of
actinin 4 and cofilin, and spots 1 for Arp2 and Arpc5. It must
be recalled, however, that such changes are not induced by
the particle internalization process per se, as they were not
observed for cells treated with the non-toxic zirconium oxide
nanoparticles.53 They are also not induced by every toxic
nanoparticle, as they were observed neither with zinc oxide53
nor with copper oxide, except for arpc5 which also decreased
in response to treatment with copper oxide.37
Overall, the proteomic results suggest that the recovery
process is a slow process. To evaluate this aspect, we deter-
mined the number of spots that showed a fast recovery. This
category was defined as spots for which the quantitative
change in the acute vs. control comparison showed an ampli-
tude at least twice that in the recovery vs. control compari-
son. Only 44 spots were identified that fell in this category
(including GCLM).
A striking result of our study was the observation that
some changes in protein levels that were not immediately sig-
nificant after exposure became significant at the end of the
72 h recovery phase. Such changes were observed both in
targeted experiments (e.g. for the LPS-dependent responses)
and in the proteomic screen. 51 spots showed such an ex-
pression profile, i.e. 21% of the total variable spots.
Functionally speaking, the results obtained when evaluat-
ing LPS-induced activities contrast with those previously de-
scribed on primary macrophages,23 in which the cytokine
and TNF productions also tended to return to normal values
during the recovery phase. This discrepancy may have several
origins. One such cause for the discrepancy could be differ-
ences in the persistence of silver between differing experi-
mental conditions. In the experiments on primary macro-
phages, measurements of silver by PIXE showed a strong
decrease (50%) in cellular silver content upon recovery, with-
out any cellular multiplication (primary macrophages are
post-mitotic in vitro). In the current experiments using the
J774 cell line, the total silver content decreased by only 15%,
and the decrease in cellular silver content is due mostly to
cell division. The simple fact that the cells are able to divide
shows that the silver concentration present in the cells is not
toxic and explains also why, generally, the cellular parameter
tends to return to normal levels. The remaining silver con-
centration may, however, may be high enough to inhibit spe-
cialized macrophage functions that depend on cell signaling,
such as LPS-dependent activities.
In this context, it is tempting to dismiss the results
obtained on the cell lines and favor those obtained using pri-
mary cells. The situation may, however, not be so simple.
First, primary macrophages in vitro survive for only a few
days once differentiated, while resident macrophages, such
as those used in experiments using cell lines, have a very
long lifespan,94,95 Furthermore, the condition in which the
results between cell lines and primary macrophages diverge
corresponds to an acute exposure to silver nanoparticles
followed by a massive exposure to bacteria (mimicked by ex-
posure to LPS), i.e. conditions that have not been tested
in vivo. Therefore, we are currently unable to determine
which system best represents the in vivo situation.
5. Conclusions
Overall, our results obtained both by targeted measurements
and by proteomic experiments involving hundreds of pro-
teins show that recovery after an acute exposure to silver
nanoparticles is a very active process that involves a massive
energy consumption, 50% higher than normal. This process
leads to the quasi restoration of cellular homeostasis within
72 hours post exposure, as confirmed by targeted experi-
ments testing the activity of enzymes, on mitochondrial func-
tion and on phagocytosis. Proteomic experiments also show,
however, that this restoration of cellular homeostasis involves
changes in the levels of many proteins, of which many are
sustained, or even amplified, at the end of the 72 hour recov-
ery period studied. The persistence of proteomic changes
might be linked with the persistence of intracellular silver
during the recovery period, which may require a long-lasting
cellular adaptation process. Some other specialized macro-
phage functions, such as LPS-induced cytokine or nitric oxide
production, did not return to normal within the 72 hour re-
covery period.
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